• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit polyclonal to PIWIL2

The current paradigm states that exit from mitosis is triggered by

February 19, 2018 by Katherine Lewis Leave a Comment

The current paradigm states that exit from mitosis is triggered by the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) acting in concert with an activator called CDC20. 1 (CDK1)-inhibitory phosphorylation was activated during mitotic departure in CDC20-exhausted cells. The phrase of an siRNA-resistant CDC20 rescued both the mitotic departure hold off and the CDK1-inhibitory phosphorylation. Furthermore, the … [Read more…]

Posted in: Blogging Tagged: Rabbit polyclonal to PIWIL2, SC-144 manufacture

Mutations in nucleophosmin (exon 12 mutations in patients with AML using

August 4, 2017 by Katherine Lewis Leave a Comment

Mutations in nucleophosmin (exon 12 mutations in patients with AML using polymerase chain reaction amplification of genomic DNA followed by the analysis of amplification items by capillary electrophoresis. (AML) can be a heterogeneous disease medically, molecularly, and cytogenetically. Around 30% of instances display repeated cytogenetic abnormalities, reciprocal translocations typically, that assist define specific entities and … [Read more…]

Posted in: Blogging Tagged: 58-56-0 IC50, Rabbit polyclonal to PIWIL2

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by